Everence Capital Management »

Cytek Biosciences shares owned by Everence Capital Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Everence Capital Management from 13F filings

Historical chart of Everence Capital Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Everence Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Everence Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $126k 14k 9.09
2023-09-30 $88k 16k 5.49